[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ITMI20011337A0 - Composizioni farmaceutiche orali a rilascio modificato del principio attivo - Google Patents

Composizioni farmaceutiche orali a rilascio modificato del principio attivo

Info

Publication number
ITMI20011337A0
ITMI20011337A0 IT2001MI001337A ITMI20011337A ITMI20011337A0 IT MI20011337 A0 ITMI20011337 A0 IT MI20011337A0 IT 2001MI001337 A IT2001MI001337 A IT 2001MI001337A IT MI20011337 A ITMI20011337 A IT MI20011337A IT MI20011337 A0 ITMI20011337 A0 IT MI20011337A0
Authority
IT
Italy
Prior art keywords
active ingredient
pharmaceutical compositions
modified release
oral pharmaceutical
oral
Prior art date
Application number
IT2001MI001337A
Other languages
English (en)
Inventor
Maria Gabriella Massironi
Original Assignee
Farmatron Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmatron Ltd filed Critical Farmatron Ltd
Priority to IT2001MI001337A priority Critical patent/ITMI20011337A1/it
Publication of ITMI20011337A0 publication Critical patent/ITMI20011337A0/it
Priority to AT02747410T priority patent/ATE302616T1/de
Priority to US10/482,461 priority patent/US7727551B2/en
Priority to PT02747410T priority patent/PT1401501E/pt
Priority to ES02747410T priority patent/ES2248576T3/es
Priority to EP02747410A priority patent/EP1401501B1/en
Priority to PCT/EP2002/006749 priority patent/WO2003002151A1/en
Priority to JP2003508389A priority patent/JP4657601B2/ja
Priority to CA2451379A priority patent/CA2451379C/en
Priority to DE60205749T priority patent/DE60205749T2/de
Priority to DK02747410T priority patent/DK1401501T3/da
Publication of ITMI20011337A1 publication Critical patent/ITMI20011337A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT2001MI001337A 2001-06-26 2001-06-26 Composizioni farmaceutiche orali a rilascio modificato del principio attivo ITMI20011337A1 (it)

Priority Applications (11)

Application Number Priority Date Filing Date Title
IT2001MI001337A ITMI20011337A1 (it) 2001-06-26 2001-06-26 Composizioni farmaceutiche orali a rilascio modificato del principio attivo
DK02747410T DK1401501T3 (da) 2001-06-26 2002-06-19 Orale farmaceutiske sammensætninger med modificeret frigivelse af den aktive ingrediens
ES02747410T ES2248576T3 (es) 2001-06-26 2002-06-19 Composiciones farmaceuticas orales con liberacion modificada del ingrediente activo.
US10/482,461 US7727551B2 (en) 2001-06-26 2002-06-19 Oral pharmaceutical compositions with modified release of the active ingredient
PT02747410T PT1401501E (pt) 2001-06-26 2002-06-19 Composicoes farmaceuticas orais com libertacao modificada do ingrediente activo
AT02747410T ATE302616T1 (de) 2001-06-26 2002-06-19 Oral anzuwendende arzneizusammensetzungen mit gesteuerter wirkstoffabgabe
EP02747410A EP1401501B1 (en) 2001-06-26 2002-06-19 Oral pharmaceutical compositions with modified release of the active ingredient
PCT/EP2002/006749 WO2003002151A1 (en) 2001-06-26 2002-06-19 Oral pharmaceutical compositions with modified release of the active ingredient
JP2003508389A JP4657601B2 (ja) 2001-06-26 2002-06-19 活性成分放出能が改良された経口医薬組成物
CA2451379A CA2451379C (en) 2001-06-26 2002-06-19 Oral pharmaceutical compositions with modified release of the active ingredient
DE60205749T DE60205749T2 (de) 2001-06-26 2002-06-19 Oral anzuwendende arzneizusammensetzungen mit gesteuerter wirkstoffabgabe

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001MI001337A ITMI20011337A1 (it) 2001-06-26 2001-06-26 Composizioni farmaceutiche orali a rilascio modificato del principio attivo

Publications (2)

Publication Number Publication Date
ITMI20011337A0 true ITMI20011337A0 (it) 2001-06-26
ITMI20011337A1 ITMI20011337A1 (it) 2002-12-26

Family

ID=11447930

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2001MI001337A ITMI20011337A1 (it) 2001-06-26 2001-06-26 Composizioni farmaceutiche orali a rilascio modificato del principio attivo

Country Status (11)

Country Link
US (1) US7727551B2 (it)
EP (1) EP1401501B1 (it)
JP (1) JP4657601B2 (it)
AT (1) ATE302616T1 (it)
CA (1) CA2451379C (it)
DE (1) DE60205749T2 (it)
DK (1) DK1401501T3 (it)
ES (1) ES2248576T3 (it)
IT (1) ITMI20011337A1 (it)
PT (1) PT1401501E (it)
WO (1) WO2003002151A1 (it)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
TWI312285B (en) 2001-10-25 2009-07-21 Depomed Inc Methods of treatment using a gastric retained gabapentin dosage
US7612112B2 (en) 2001-10-25 2009-11-03 Depomed, Inc. Methods of treatment using a gastric retained gabapentin dosage
US20050158380A1 (en) * 2002-06-07 2005-07-21 Manish Chawla Sustained release oral dosage forms of gabapentin
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
EP1510208A1 (en) 2003-08-22 2005-03-02 Fournier Laboratories Ireland Limited Pharmaceutical composition comprising a combination of metformin and statin
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
WO2005041928A1 (en) * 2003-10-31 2005-05-12 Alza Corporation Compositions and dosage forms for ehnanced absorption of iron
ITMI20032399A1 (it) 2003-12-09 2005-06-10 Zambon Spa Composizione farmaceutica contenente gabapentina.
US20080286359A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US7645459B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of bisphosphonates
US7645460B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of risedronate
US20080287400A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
PT1812072E (pt) * 2004-11-17 2008-11-04 Ares Trading Sa Formulações de benzotiazole e sua utilização
UY29445A1 (es) * 2005-03-30 2006-10-02 Generex Pharm Inc Composiciones para la transmisión transmucosa oral de la metformina
US20090176882A1 (en) 2008-12-09 2009-07-09 Depomed, Inc. Gastric retentive gabapentin dosage forms and methods for using same
ES2288117B1 (es) * 2006-05-08 2008-12-01 Combino Pharm, S.L. Composicion farmaceutica solida de gabapentina.
US20090036414A1 (en) * 2007-08-02 2009-02-05 Mutual Pharmaceutical Company, Inc. Mesalamine Formulations
CA2638240C (en) * 2008-08-29 2010-02-02 Alexander Macgregor Method of treating dysglycemia and glucose excursions
WO2010120892A2 (en) * 2009-04-14 2010-10-21 The Regents Of The University Of California Improved oral drug devices and drug formulations
DK2432455T3 (en) 2009-05-18 2015-02-16 Sigmoid Pharma Ltd A composition comprising oil droplets
CN101703486B (zh) * 2009-11-24 2011-11-09 上海复旦复华药业有限公司 一种氟他胺片剂及其制备方法
US8581001B2 (en) 2010-04-16 2013-11-12 Codman & Shurtleff Metformin-cysteine prodrug
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
CN102119931B (zh) * 2011-02-21 2013-02-13 寿光富康制药有限公司 一种盐酸二甲双胍缓释片及其制备方法
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201304662D0 (en) 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
JP6210640B2 (ja) * 2014-06-19 2017-10-11 大原薬品工業株式会社 ホリナートカルシウム含有錠
DK3215127T3 (da) 2014-11-07 2021-02-01 Sublimity Therapeutics Ltd Sammensætninger omfattende cyclosporin
GB201511284D0 (en) * 2015-06-26 2015-08-12 Univ Witwatersrand Jhb An oral pharmaceutical dosage form for the delivery of a peptide and/or protein
JP2017210493A (ja) * 2017-09-08 2017-11-30 大原薬品工業株式会社 ホリナートカルシウム含有錠
IT201800011120A1 (it) 2018-12-14 2020-06-14 Dpl Pharma S P A Composizioni farmaceutiche orali solide per la somministrazione di mesalazina o suoi derivati
JP2021036003A (ja) * 2020-12-05 2021-03-04 大原薬品工業株式会社 ホリナートカルシウム含有錠
CN117363320B (zh) * 2023-12-07 2024-02-13 黑龙江省鑫博鑫交通科技有限公司 一种公路用融雪剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8630273D0 (en) * 1986-12-18 1987-01-28 Til Medical Ltd Pharmaceutical delivery systems
TW209174B (it) 1991-04-19 1993-07-11 Takeda Pharm Industry Co Ltd
JPH08283146A (ja) * 1995-10-23 1996-10-29 Boehringer Mannheim Gmbh 成形され、圧縮された徐放性単位投薬形態の調製法およびこうして得られた圧縮単位投薬形態
WO1999021534A1 (en) * 1997-10-27 1999-05-06 Merck Patent Gmbh Solid state solutions and dispersions of poorly water soluble drugs
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
AU5680100A (en) * 1999-06-14 2001-01-02 Cosmo S.P.A. Controlled release and taste masking oral pharmaceutical compositions

Also Published As

Publication number Publication date
ATE302616T1 (de) 2005-09-15
DK1401501T3 (da) 2006-01-09
US20040213844A1 (en) 2004-10-28
PT1401501E (pt) 2005-10-31
WO2003002151A1 (en) 2003-01-09
EP1401501A1 (en) 2004-03-31
JP4657601B2 (ja) 2011-03-23
CA2451379A1 (en) 2003-01-09
CA2451379C (en) 2010-04-06
DE60205749D1 (de) 2005-09-29
ITMI20011337A1 (it) 2002-12-26
US7727551B2 (en) 2010-06-01
DE60205749T2 (de) 2006-03-09
JP2004534833A (ja) 2004-11-18
EP1401501B1 (en) 2005-08-24
ES2248576T3 (es) 2006-03-16

Similar Documents

Publication Publication Date Title
ITMI20011337A0 (it) Composizioni farmaceutiche orali a rilascio modificato del principio attivo
HRPK20040323B3 (en) Oral dosage form for propiverine or its pharmaceutically acceptable salts with an extended release of the active ingredient
NO20033556L (no) Farmasöytiske formuleringer
DE60307677D1 (de) Dispergierbare pharmazeutische zusammensetzungen
CY2007031I2 (el) Συνθεση στοματικης δοσολογιας παρατεταμενης απελευθερωσης
AU2002346973A1 (en) Oral Dosage Form for Propiverine or its Pharmaceutically Acceptable Salts with an Extended Release of the Active Ingredient
FR2795324B1 (fr) Compositions pharmaceutiques stabilisees
NO20033384L (no) Farmasoytisk formulering
ITMI991316A0 (it) Composizioni farmaceutiche orali a rilascio modificato di mesalazina
PT1501534E (pt) Formulacoes farmaceuticas
NO20033785D0 (no) Farmasöytisk formulering
ITMI20011338A0 (it) Composizioni farmaceutiche orali a rilascio immediato del principio attivo
EE05020B1 (et) Glburiidi ravimkoostis
NO20035627D0 (no) Farmasöytisk formulering
IS7051A (is) Lyfjasamsetningar
FI20000780A (fi) Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
DE60217390D1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
NO20043007L (no) Farmasoytisk suspensjon for oral administrering
NO20040857L (no) Ny oral forlenget frigivelses doseringsform.
NO20043633L (no) Oral doseringsform for kontrollert medikamentfrigivning
DE10291905D2 (de) Pharmazeutische Zusammensetzung
NO331169B1 (no) Krystallinsk form av et fenyletanolamin, fremstilling derav og farmasoytisk preparat og legemiddel omfattende den samme
ITMI20011457A0 (it) Composizione farmaceutica a rilascio modificato contenente bupropionehc1 come sostanza attiva
DE10107261B4 (de) Pharmazeutische Zusammensetzung
ITMI20020639A0 (it) Composizioni farmaceutiche comprendenti come principio attivo 1-isopropil-3°(4-m-toluidino-3-pridil)sulfonil -urea